Dr. Jorg Taubel will be attending the AGAH Annual Meeting. As a pivotal event in the field of clinical pharmacology, the AGAH Annual Meeting brings together experts and professionals from around the world.

Since 1999, these gatherings have been a cornerstone of collaboration with esteemed international partner organisations, including the American College of Clinical Pharmacology (ACCP), the French Club Phase 1, the Belgian Association of Phase-1 Units (BAPU), and the British Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI).

‍

Dr. Taubel's participation underscores our commitment to advancing knowledge and fostering collaboration in clinical pharmacology.

‍

To find out more: https://www.agah.eu/events/annual-meetings/ 

Latest news

Richmond Pharmacology highlights encouraging first-in-human results for Regeneron's investigational RNAi therapy in MASLD

November 12, 2026
NEJM publication and AASLD presentation reports that 79% of treated participants with MASLD and available measurements achieved normal liver fat levels at Week 24 after a single dose of CIDEBsiRNA, alongside improvements in markers of liver injury.
Read more

Upcoming Event

AHA Scientific Sessions 2026

14 - 16 November 2026
Richmond Pharmacology is excited to join the AHA Scientific Sessions 2026 in 14–16 November 2026, on 14–16 November 2026, hosted by the American Heart Association.
View event